Physician profile
Shiv Patel
NPI 1891149985
$3,836.77
in general payments reported to CMS, 2019-2025
18 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,104 · 2022: $1,173 · 2023: $1,038 · 2024: $85.71 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,247.39 | 2021-2024 | Intellis Adaptivestim, V-Loc 180 |
| Nevro Corp. | $895.41 | 2021-2023 | Senza |
| Boston Scientific Corporation | $395.53 | 2023-2025 | Wavewriter Alpha Prime 16, General - Vascular Intervention, Intracept |
| Saluda Medical Americas, INC. | $360.08 | 2022-2023 | Evoke Scs |
| Abbott Laboratories | $324.64 | 2021-2025 | Proclaim |
| Teva Pharmaceuticals USA, INC. | $154.64 | 2022-2023 | Ajovy |
| Abbvie INC. | $107.79 | 2021-2022 | |
| Bioventus LLC | $101.88 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $65.82 | 2023-2024 | Spinejack, N/A |
| Biohaven Pharmaceutical Holding Company LTD. | $36.30 | 2022 | |
| Allergan, INC. | $33.55 | 2021 | |
| Avanos Medical | $24.84 | 2024 | Coolief* Cooled Radiofrequency |
| Relievant Medsystems, INC. | $20.80 | 2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.12 | 2022 | |
| Impel Pharmaceuticals INC. | $13.86 | 2023 | Trudhesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.09 | 2022 | |
| Ibsa Pharma INC. | $12.70 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiv Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.